What is Theravance Biopharma's capex?

Theravance Biopharma (TBPH) reported capex of $8K in Q4 2025.

How has Theravance Biopharma's capex changed year-over-year?

Theravance Biopharma's capex decreased by 95.8% year-over-year, from $190K to $8K.

What is the long-term trend for Theravance Biopharma's capex?

Over 3 years (2021 to 2024), Theravance Biopharma's capex has grown at a -54.0% compound annual growth rate (CAGR), from $3.41M to $332K.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Theravance Biopharma TBPH CapEx

Discontinued — last reported Q4 '25

CapEx at other companies

Zevra Therapeutics, Inc.ZVRA

$35K-64.6%

LQD

Liquidia CorporationLQDA

$2.83M+758%

United TherapeuticsUTHR

$100.8M+34.6%

PrecigenPGEN

$258K-58.5%

Ultragenyx PharmaceuticalRARE

$1M0.0%

OrganonOGN

$37M+15.6%

Other financials

Income statement

See full

Revenue$17.7M+15.0%

Operating income-$9.5M+34.3%

Net income-$4.9M+63.7%

EPS (diluted)-$0.10+63.0%

Balance sheet

See full

Cash & equivalents$288.1M+160%

Total debt$40.5M-15.9%

Total equity$290.6M+75.1%

Total assets$472.3M+37.5%

Cash flow

See full

Operating cash flow$73.3M+70.3%

Free cash flow$59.6M+5,560%

Valuation

See full

Market cap$890.32M+67.5%

Enterprise value$642.72M+37.0%

P/E7.8×—

P/S8.1×0.0×

Profitability

See full

Gross margin60.8%—

Operating margin1.2%+0.6pp

Net margin104.3%+71.4pp

FCF margin221.9%+206pp

Returns & leverage

See full

Return on equity50.2%+36.2pp

Debt / equity0.1×-0.2×

Current ratio13.1×+8.4×

Where this comes from

Reported directly by Theravance Biopharma in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireProductiveAssets.

The official record: Theravance Biopharma’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Theravance Biopharma's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Theravance Biopharma's capex?: Theravance Biopharma (TBPH) reported capex of $8K in Q4 2025.
How has Theravance Biopharma's capex changed year-over-year?: Theravance Biopharma's capex decreased by 95.8% year-over-year, from $190K to $8K.
What is the long-term trend for Theravance Biopharma's capex?: Over 3 years (2021 to 2024), Theravance Biopharma's capex has grown at a -54.0% compound annual growth rate (CAGR), from $3.41M to $332K.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.